CAS: 425613-09-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SJ000291942 REF: IN-DA01EO6LCAS: 425613-09-8 | 99% | 160.00 €~659.00 € | Fri 13 Dec 24 |
 | SJ000291942 REF: TM-T4662CAS: 425613-09-8 | 99.07% | 45.00 €~582.00 € | Fri 20 Dec 24 |
 | SJ000291942 REF: 3D-ASA61309CAS: 425613-09-8 | Min. 95% | To inquire | Fri 24 Jan 25 |
SJ000291942
CAS:425613-09-8
Formula:
C16H15FN2O4
Purity:
99%
Color and Shape:
Solid
Molecular weight:
318.2997
Ref: IN-DA01EO6L
| 5mg | 160.00 € | ||
| 10mg | 181.00 € | ||
| 50mg | 193.00 € | ||
| 100mg | 327.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
SJ000291942
CAS:425613-09-8
SJ000291942 is an activator of the canonical bone morphogenetic proteins (BMP) signaling pathway.
Formula:
C16H15FN2O4
Purity:
99.07%
Color and Shape:
Solid
Molecular weight:
318.3
Ref: TM-T4662
| 2mg | 45.00 € | ||
| 5mg | 66.00 € | ||
| 10mg | 104.00 € | ||
| 25mg | 227.00 € | ||
| 50mg | 393.00 € | ||
| 100mg | 582.00 € | ||
| 1mL*10mM (DMSO) | 75.00 € |
Estimated delivery in United States, on Friday 20 Dec 2024
SJ000291942
CAS:425613-09-8
SJ000291942 is a drug that inhibits the growth of cancer cells in the laboratory. It …
Formula:
C16H15FN2O4
Purity:
Min. 95%
Molecular weight:
318.3 g/mol
Ref: 3D-ASA61309
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 24 Jan 2025
